# To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.

Study · id `cardio:ct-nct07097441` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07097441](<https://clinicaltrials.gov/study/NCT07097441>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07097441

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: High blood pressure; Heart rhythm problems  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT07097441. Randomized; triple masking; primary purpose treatment. Start 2025-03-12 (actual); primary completion 2025-06-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT07097441, source copy `cardio:ctgov-nct07097441-2025-07-31`, retrieved 2026-10-26)
- Started: 2025-03-12 (actual) (ClinicalTrials.gov record NCT07097441, source copy `cardio:ctgov-nct07097441-2025-07-31`, retrieved 2026-10-26)
- Primary completion: 2025-06-04 (actual) (ClinicalTrials.gov record NCT07097441, source copy `cardio:ctgov-nct07097441-2025-07-31`, retrieved 2026-10-26)
- Completion: 2025-06-04 (actual) (ClinicalTrials.gov record NCT07097441, source copy `cardio:ctgov-nct07097441-2025-07-31`, retrieved 2026-10-26)
- Countries: Pakistan (ClinicalTrials.gov record NCT07097441, source copy `cardio:ctgov-nct07097441-2025-07-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07097441-2025-07-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.
- Condition: Tachycardia
- Condition: Hypertension
- Condition: Hypoxia
- Condition: Hyperventilation
- Condition: Residual Paralysis, Post Anesthesia
- Intervention (Drug): Placebo drug ( normal saline )
- Intervention (Drug): neostigmine (reversal agent)
- Lead sponsor: Ziauddin University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: f43065e2f0a7a74f26d728a2f89cac295b2c80a76041f2259f63a6ee64728d3a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
